These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28859216)

  • 1. Evaluating the Multitarget Effects of Combinations through Multistep Clustering of Pharmacological Data: the Example of the Commercial Preparation Iberogast.
    Abdel-Aziz H; Kelber O; Lorkowski G; Storr M
    Planta Med; 2017 Oct; 83(14-15):1130-1140. PubMed ID: 28859216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5.
    Rösch W; Liebregts T; Gundermann KJ; Vinson B; Holtmann G
    Phytomedicine; 2006; 13 Suppl 5():114-21. PubMed ID: 16978851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Iberogast: a modern phytotherapeutic combined herbal drug for the treatment of functional disorders of the gastrointestinal tract (dyspepsia, irritable bowel syndrome)--from phytomedicine to "evidence based phytotherapy." A systematic review].
    Saller R; Pfister-Hotz G; Iten F; Melzer J; Reichling J
    Forsch Komplementarmed Klass Naturheilkd; 2002 Dec; 9 Suppl 1():1-20. PubMed ID: 12618546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STW 5 (Iberogast®)--a safe and effective standard in the treatment of functional gastrointestinal disorders.
    Ottillinger B; Storr M; Malfertheiner P; Allescher HD
    Wien Med Wochenschr; 2013 Feb; 163(3-4):65-72. PubMed ID: 23263639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [STW 5/Iberogast: multi-target-action for treatment of functional dyspepsia and irritable bowel syndrome].
    Allescher HD; Wagner H
    Wien Med Wochenschr; 2007; 157(13-14):301-7. PubMed ID: 17704976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of gastrointestinal motility beyond metoclopramide and domperidone : Pharmacological and clinical evidence for phytotherapy in functional gastrointestinal disorders.
    Madisch A; Vinson BR; Abdel-Aziz H; Kelber O; Nieber K; Kraft K; Storr M
    Wien Med Wochenschr; 2017 May; 167(7-8):160-168. PubMed ID: 28424994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of Action of STW 5 in Functional Dyspepsia and IBS: The Origin of Multi-Target.
    Allescher HD; Abdel-Aziz H
    Dig Dis; 2017; 35 Suppl 1():18-24. PubMed ID: 29421789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evidence-based medicine and phytotherapy for functional dyspepsia and irritable bowel syndrome: a systematic analysis of evidence for the herbal preparation Iberogast].
    Holtmann G; Adam B; Vinson B
    Wien Med Wochenschr; 2004 Nov; 154(21-22):528-34. PubMed ID: 15638072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast).
    Melzer J; Rösch W; Reichling J; Brignoli R; Saller R
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1279-87. PubMed ID: 15606389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herbal Preparation STW 5 for Functional Gastrointestinal Disorders: Clinical Experience in Everyday Practice.
    Lapina TL; Trukhmanov AS
    Dig Dis; 2017; 35 Suppl 1():30-35. PubMed ID: 29421814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional gastrointestinal disorders in children: Effectivity, safety, and tolerability of the herbal preparation STW-5 (Iberogast®) in general practice.
    Michael R; Bettina V; Eckehard L
    Complement Ther Med; 2022 Dec; 71():102873. PubMed ID: 35998755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A plant extract and its modified preparation in functional dyspepsia. Results of a double-blind placebo controlled comparative study].
    Madisch A; Melderis H; Mayr G; Sassin I; Hotz J
    Z Gastroenterol; 2001 Jul; 39(7):511-7. PubMed ID: 11505331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia.
    Rösch W; Vinson B; Sassin I
    Z Gastroenterol; 2002 Jun; 40(6):401-8. PubMed ID: 12055663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spasmolytic and tonic effect of Iberogast (STW 5) in intestinal smooth muscle.
    Ammon HP; Kelber O; Okpanyi SN
    Phytomedicine; 2006; 13 Suppl 5():67-74. PubMed ID: 16978852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STW 5 (Iberogast) Therapy in Gastrointestinal Functional Disorders.
    Malfertheiner P
    Dig Dis; 2017; 35 Suppl 1():25-29. PubMed ID: 29421817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergy quantifications to identify individual contributions of combination partners to the overall activity - The example of STW 5.
    Ulrich-Merzenich G; Welslau L; Aziz-Kalbhenn H; Kelber O; Shcherbakova A
    Phytomedicine; 2019 Jul; 60():153013. PubMed ID: 31326154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multitarget therapy--the future of treatment for more than just functional dyspepsia.
    Wagner H
    Phytomedicine; 2006; 13 Suppl 5():122-9. PubMed ID: 16772111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-target Treatment for Irritable Bowel Syndrome with STW 5: Pharmacological Modes of Action.
    Allescher HD; Burgell R; Malfertheiner P; Mearin F
    J Gastrointestin Liver Dis; 2020 Jun; 29(2):227-233. PubMed ID: 32530990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phytotherapy in Functional Gastrointestinal Disorders.
    Kelber O; Bauer R; Kubelka W
    Dig Dis; 2017; 35 Suppl 1():36-42. PubMed ID: 29421793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radical scavenging and anti-inflammatory properties of STW 5 (Iberogast) and its components.
    Schempp H; Weiser D; Kelber O; Elstner EF
    Phytomedicine; 2006; 13 Suppl 5():36-44. PubMed ID: 16777393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.